Corvus Pharmaceuticals, Inc. (BX:C17) IPO

Corvus Pharmaceuticals, Inc.

IPO

Priced at US$15.00 a share on Mar 22, 2016.

Price
US$15.00 a share
Shares offered
4,700,000 shares of common stock
Offering size
US$70.5 million
Underwriters' option
Up to 705,000 more shares
Listing
CRVS on the Nasdaq Global Market
Underwriters
Credit Suisse, Cowen and Company, Guggenheim Securities, Cantor Fitzgerald & Co., BTIG · In the order on the cover
Shares delivered
On or about Mar 29, 2016

Steps

StepWhen
Draft sent to the SEC in confidenceNov 6, 2015
Filed publiclyJan 4, 2016
Amended twiceNewest Mar 10, 2016
Shares registered with an exchangeMar 16, 2016
Declared effective by the SECMar 22, 2016
Final prospectus, with the priceMar 24, 2016

From the cover of the final prospectus (424B4) filed Mar 24, 2016